The histopathologic and molecular basis for the diagnosis of histiocytic sarcoma and histiocyte-associated lymphoma of mice

Veterinary Pathology

Volumn 47, Issue 3, 2010, Pages 434-445

  Hao, X ^a,b   Fredrickson, T N ^a   Chattopadhyay, S K ^a   Han, W ^c   Qi, C F ^a   Wang, Z ^d,e   Ward, J M ^a   Hartley, J W ^a   Morse III, Herbert C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

Author keywords

Histiocyte associated lymphoma; Histiocytic sarcoma; Immunohistochemistry; Lymphoma; Southern blotting; Tissue microarray

Indexed keywords

DIFFERENTIATION ANTIGEN; GALECTIN 3; LYSOZYME; MONOCYTE MACROPHAGE DIFFERENTIATION ANTIGEN; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN; PAX5 PROTEIN, MOUSE; TRANSCRIPTION FACTOR PAX5; TUMOR MARKER;

ANIMAL; ANIMAL DISEASE; ARTICLE; FEMALE; HISTIOCYTIC SARCOMA; LYMPHOMA; MALE; METABOLISM; MOUSE; PATHOLOGY; RODENT DISEASE;

ANIMALS; ANTIGENS, DIFFERENTIATION; B-CELL-SPECIFIC ACTIVATOR PROTEIN; FEMALE; GALECTIN 3; HISTIOCYTIC SARCOMA; LYMPHOMA; MALE; MICE; MURAMIDASE; RODENT DISEASES; TUMOR MARKERS, BIOLOGICAL;

MUS;

EID: 77954502166     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985810363705     Document Type: Article

References (56)

1. Achten R., Verhoef G., Vanuytsel L., De Wolf Peeters C.: Histiocyte rich, T cell rich B cell lymphoma: a distinct diffuse large B cell lymphoma subtype showing characteristic morphologic and immunophenotypic features. Histopathology 40:31-45, 2002.
2. Akashi K., Traver D., Miyamoto T., Weissman IL: A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404:193-197, 2000.
3. Arber DA, Strickler JG, Chen YY, Weiss LM: Splenic vascular tumors: a histologic, immunophenotypic, and virologic study. Am J Surg Pathol 21:827-835, 1997.
4. Bauer SR, Holmes KL, Morse HC III, Potter M.: Clonal relationship of the lymphoblastic cell line P388 to the macrophage cell line P388D1 as evidenced by immunoglobulin gene rearrangements and expression of cell surface antigens. J Immunol 136:4695-4699, 1986.
5. Carrasco DR, Fenton T., Sukhdeo K., Protopopova M., Enos M., You MJ, Di Vizio D., Nogueira C., Stommel J., Pinkus GS, Fletcher C., Hornick JL, Cavenee WK, Furnari FB, Depinho RA: The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans. Cancer Cell 9:379-390, 2006.
6. Chattopadhyay SK, Lowy DR, Teich NM, Levine AS, Rowe WP: Qualitative and quantitative studies of AKR type murine leukemia virus sequences in mouse DNA. Cold Spring Harbor Symp Quant Biol 39:1085-1101, 1974.
7. Cobaleda C., Busslinger M.: Developmental plasticity of lymphocytes. Curr Opin Immunol 20:139-148, 2008.
8. Coindre JM: Immunohistochemistry in the diagnosis of soft tissue tumours. Histopathology 43:1-16, 2003.
9. Copie Bergman C., Wotherspoon AC, Norton AJ, Diss TC, Isaacson PG: True histiocytic lymphoma: a morphologic, immunohistochemical, and molecular genetic study of 13 cases. Am J Surg Pathol 22:1386-1392, 1998.
10. Cotta CV, Zhang Z., Kim HG, Klug CA: Pax5 determines B versus T cell fate and does not block early myeloid lineage development. Blood 101:4342-4346, 2003.
11. Davidson WF, Pierce JH, Rudikoff S., Morse HC III: Relationships between B cell and myeloid differentiation: studies with a B lymphocyte progenitor line, HAFTL 1. J Exp Med 168:389-407, 1988.
12. Dawe CJ, Potter M.: Morphologic and biologic progression of a lymphoid neoplasm of the mouse in vivo and in vitro. Am J Pathol 33:603, 1957.
13. Dogan A., Burke JS, Goteri G., Stitson RN, Wotherspoon AC, Isaacson PG: Micronodular T cell/histiocyte rich large B cell lymphoma of the spleen: histology, immunophenotype, and differential diagnosis. Am J Surg Pathol 27:903-911, 2003.
14. Dunn TB: Normal and pathologic anatomy of the reticular tissue in laboratory mice, with a classification and discussion of neoplasms. J Natl Cancer Inst 14:1281-1433, 1954.
15. Falk S., Stutte HJ, Frizzera G.: Littoral cell angioma: a novel splenic vascular lesion demonstrating histiocytic differentiation. Am J Surg Pathol 15:1023-1033, 1991.
16. Feldman AL, Arber DA, Pittaluga S., Martinez A., Burke JS, Raffeld M., Camos M., Warnke R., Jaffe ES: Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood 111:5433-5439, 2008.
17. Feldman AL, Minniti C., Santi M., Downing JR, Raffeld M., Jaffe ES: Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin. Lancet Oncol 5:248-250, 2004.
18. Fraga M., Sánchez Verde L., Forteza J., García Rivero A., Piris MA: T cell/histiocyte rich large B cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma. Histopathology 41:216-229, 2002.
19. Franz T., Löhler J., Fusco A., Pragnell I., Nobis P., Padua R., Ostertag W.: Transformation of mononuclear phagocytes in vivo and malignant histiocytosis caused by a novel murine spleen focus forming virus. Nature 315:149-151, 1985.
20. Fredrickson TN, Hartley JH, Morse HC, Chattopadhyay SK, Lennert K.: Classification of mouse lymphomas. Curr Top Microbiol Immunol 194:109-116, 1995.
21. Frith CH, Davis TM, Zolotor LA, Townsend JW: Histiocytic lymphoma in the mouse. Leuk Res 4:651-662, 1980.
22. Frith CH, Ward JM, Chandra M.: The morphology, immunohistochemistry, and incidence of hematopoietic neoplasms in mice and rats. Toxicol Pathol 21:206-218, 1993.
23. Hao XP, Pretlow TG, Rao JS, Pretlow TP: Beta catenin expression is altered in human colonic aberrant crypt foci. Cancer Res 61: 8085-8088, 2001.
24. Hartley JW, Chattopadhyay SK, Lander MR, Taddesse Heath L., Naghashfar Z., Morse HC III, Fredrickson TN: Accelerated appearance of multiple B cell lymphoma types in NFS/N mice congenic for ecotropic murine leukemia viruses. Lab Invest 80:159-169, 2000.
25. Hedrick SM, Germain RN, Bevan MJ, Dorf M., Engel I., Fink P., Gascoignec N., Heber Katz E., Kapp J., Kaufmann Y., Kaye J., Melchers F., Pierce C., Schwartz RH, Sorensen C., Taniguchi M., Davis MM: Rearrangement and transcription of a T cell receptor beta-chain gene in different T cell subsets. Proc Natl Acad Sci U S A 82:531-535, 1985.
26. Hoyer KK, French SW, Turner DE, Nguyen MT, Renard M., Malone CS, Knoetig S., Qi CF, Su TT, Cheroutre H., Wall R., Rawlings DJ, Morse HC III, Teitell MA: Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma. Proc Natl Acad Sci U S A 99:14392-14397, 2002.
27. Jaffe ES, Banks PM, Nathwani B., Said J., Swerdlow SH: Recommendations for the reporting of lymphoid neoplasms: a report from the association of directors of anatomic and surgical pathology: the Ad Hoc Committee on Reporting of Lymphoid Neoplasms. Hum Pathol 33:1064-1068, 2002.
28. Jaffe ES, Harris NL, Stein H., Vardiman JW: Pathology and genetics of tumours of hematopoietic and lymphoid tissues. IARC Press, Washignton DC, 2001.
29. Klinken SP, Alexander WS, Adams JM: Hemopoietic lineage switch: v raf oncogene converts Emu myc transgenic B cells into macrophages. Cell 53:857-867, 1988.
30. Kogan SC, Ward JM, Anver MR, Berman JJ, Brayton C., Cardiff RD, Carter JS, de Coronado S., Downing JR, Fredrickson TN, Haines DC, Harris AW, Harris NL, Hiai H., Jaffe ES, MacLennan IC, Pandolfi PP, Pattengale PK, Perkins AS, Simpson RM, Tuttle MS, Wong JF, Morse HC III; Hematopathology Subcommittee of the Mouse Models of Human Cancers Consortium: Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood 100:238-245, 2002.
31. Kondo M., Weissman IL, Akashi K.: Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91:661-672, 1997.
32. Lacaud G., Carlsson L., Keller G.: Identification of a fetal hematopoietic precursor with B cell, T cell, and macrophage potential. Immunity 9:827-838, 1998.
33. Lacroix Triki M., Lacoste Collin L., Jozan S., Charlet JP, Caratero C., Courtade M.: Histiocytic sarcoma in C57BL/6J female mice is associated with liver hematopoiesis: review of 41 cases. Toxicol Pathol 31:304-309, 2003.
34. Lang RB, Stanton LW, Marcu KB: On immunoglobulin heavy chain gene switching: two gamma 2b genes are rearranged via switch sequences in MPC 11 cells but only one is expressed. Nucleic Acids Res 10:611-630, 1982.
35. Lee SH, Starkey PM, Gordon S.: Quantitative analysis of total macrophage content in adult mouse tissues: immunochemical studies with monoclonal antibody F4/80. J Exp Med 161: 475-489, 1985.
36. Lim MS, Beaty M., Sorbara L., Cheng RZ, Pittaluga S., Raffeld M., Jaffe ES: T cell/histiocyte rich large B cell lymphoma: a heterogeneous entity with derivation from germinal center B cells. Am J Surg Pathol 26:1458-1466, 2002.
37. Lund AH, Turner G., Trubetskoy A., Verhoeven E., Wientjens E., Hulsman D., Russell R., DePinho RA, Lenz J., van Lohuizen M.: Genome wide retroviral insertional tagging of genes involved in cancer in Cdkn2a deficient mice. Nat Genet 32:160-165, 2002.
38. McKnight AJ, MacFarland AJ, Dri P., Turley L., Willis AC, Gordon S.: Molecular cloning of F4/80, a murine macrophage restricted cell surface glycoprotein with homology to the G protein linked transmembrane 7 hormone receptor family. J Biol Chem 271:486-489, 1996.
39. Mikkola I., Heavey B., Horcher M., Busslinger M.: Reversion of B cell commitment upon loss of Pax5 expression. Science 297:110- 113, 2002.
40. Montecino Rodriguez E., Dorshkind K.: Identification of B/macrophage progenitors in adult bone marrow. Semin Immunol 14:371- 376, 2002.
41. Morse HC III, Anver MR, Fredrickson TN, Haines DC, Harris AW, Harris NL, Jaffe ES, Kogan SC, MacLennan IC, Pattengale PK, Ward JM: Hematopathology Subcommittee of the Mouse Models of Human Cancers Consortium: Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 100: 246-258, 2002.
42. Morse HC III, Chattopadhyay SK, Makino M., Fredrickson TN, Hügin AW, Hartley JW: Retrovirus induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS 6:607-621, 1992.
43. Morse HC III, Qi CF, Chattopadhyay SK, Hori M., Taddesse Heath L., Ozato K., Hartley JW, Taylor BA, Ward JM, Jenkins NA, Copeland NG, Fredrickson TN: Combined histologic and molecular features reveal previously unappreciated subsets of lymphoma in AKXD recombinant inbred mice. Leuk Res 25:719-733, 2001.
44. Nutt SL, Heavey B., Rolink AG, Busslinger M.: Commitment to the B lymphoid lineage depends on the transcription factor Pax5. Nature 401:556-562, 1999.
45. Park SS, Kim JS, Tessarollo L., Owens JD, Peng L., Han SS, Chung ST, Torrey TA, Cheung WC, Polakiewicz RD, McNeil N., Ried T., Mushinski JF, Morse HC III, Janz S.: Insertion of c Myc into IgH induces B cell and plasma cell neoplasms in mice. Cancer Res 65:1306-1315, 2005.
46. Principato M., Cleveland JL, Rapp UR, Holmes KL, Pierce JH, Morse HC III, Klinken SP: Transformation of murine bone marrow cells with combined v raf v myc oncogenes yields clonally related mature B cells and macrophages. Mol Cell Biol 10:3562-3568, 1990.
47. Rappaport H.: Tumors of the hematopoietic system. In: Atlas of Tumor Pathology, pp. 97-161. Armed Forces Institute of Pathology, Washington DC, 1966.
48. Rolink A., Nutt S., Busslinger M., ten Boekel E., Seidl T., Andersson J., Melchers F.: Differentiation, dedifferentiation, and redifferentiation of B lineage lymphocytes: roles of the surrogate light chain and the Pax5 gene. Cold Spring Harb Symp Quant Biol 64:21-25, 1999.
49. Rolink AG, Schaniel C., Bruno L., Melchers F.: In vitro and in vivo plasticity of Pax5 deficient pre B I cells. Immunol Lett 82:35-40, 2002.
50. Rolink AG, Schaniel C., Melchers F.: Stability and plasticity of wild type and Pax5 deficient precursor B cells. Immunol Rev 187:87-95, 2002.
51. Schaller E., MacFarlane AJ, Rupec RA, Gordon S., McKnight AJ, Pfeffer K.: Inactivation of the F4/80 protein in the mouse germ line. Mol Cell Biol 22:8035-8043, 2002.
52. Taddesse Heath L., Chattopadhyay SK, Dillehay DL, Lander MR, Nagashfar Z., Morse HC III, Hartley JW: Lymphomas and high level expression of murine leukemia viruses in CFW mice. J Virol 74:6832-6837, 2000.
53. Ward JM, Nikolov NP, Tschetter JR, Kopp JB, Gonzalez FJ, Kimura S, Siegel RM: Progressive glomerulonephritis and histiocytic sarcoma associated with macrophage functional defects in CYP1B1 deficient mice. Toxicol Pathol 32:710-718, 2004.
54. Ward JM, Sheldon W.: Expression of mononuclear phagocyte antigens in histiocytic sarcoma of mice. Vet Pathol 30:560-565, 1993.
55. Yu D., Allman D., Goldschmidt MH, Atchison ML, Monroe JG, Thomas Tikhonenko A.: Oscillation between B lymphoid and myeloid lineages in Myc induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway. Blood 101:1950-1955, 2003.
56. Zhu, D., Qi CF, Morse HC III, Janz S., Stevenson FK: Deregulated expression of the Myc cellular oncogene drives development of mouse "Burkitt like" lymphomas from naive B cells. Blood 105:2135-2137, 2005.